Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS views and news. Opt-in with us: www.register.msviewsandnews.org


~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.


Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

=================================================


Sunday, August 19, 2018

A Here's How to Track Changes in Your MS Symptoms:

Symptom Diary for Multiple Sclerosis
Put a notebook on your nightstand or use a free app on your smartphone. Just make sure you note your symptoms, energy level, mood, medicine, and activity.


Multiple sclerosis (MS) symptoms come and go. One day you're fine, but the next you may be too tired to get out of bed. Lots of things can affect the way you feel, from the weather to the medicines you take. A diary can help you track your symptoms and look for patterns that may explain why they're happening.

woman with diary Your diary doesn't have to be fancy. You can write it by hand in a journal you keep near your bed. Keep a log of how you feel every day and what you were doing when your symptoms started. You might write, "Yesterday I went shopping. I barely slept last night. Today, my symptoms were worse. My left arm felt weaker than my right."

woman with tablet  GO DIGITAL if this is easiest
Free apps can help you manage your MS on your smartphone or tablet. Some let you track your symptoms along with your energy level, mood, medicines, and activity. Others sync the way you feel to the day's weather forecast and let you share your journal with your doctor.

 
woman feeling dizzy Learn the Signs of MS
To keep an accurate log, you need to know what to look for. Some common MS symptoms you may have:

  • Intense fatigue that starts early in the morning or comes on suddenly and gets worse
  • Weakness in your legs and feet that makes it hard to walk
  • Numbness or tingling in your arms, legs, or face
  • Muscle stiffness and spasms
  • Double or blurred vision, or fast eye movements
  • Dizziness and balance problems

Things to write in your diary or journal: 

Under the day and date, write down your symptom and add details like:
  • When it started and ended
  • Whether it was something new or you've had it before
  • How severe it was on a scale of 1 to 5
  • What was happening when it started (for example, a hot day or you were exercising)
  • How it affected your activity
  • What you did to treat it, and whether that helped

How to track a Flare-up (exacerbation, Pseudo or full scale)
When your symptoms strike up again after a period of calm, it's called a relapse. They can be mild and barely noticeable, or intense enough to interrupt your life and job. Use your diary to record any changes. Share this info with your doctor so you get the right treatment.

Click here to continue -- then skipping to page 7


::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 

CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: 
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Friday, August 17, 2018

MRI Can Predict Progression to MS in Patients With Clinically Isolated Syndrome

Published on: August 15, 2018

David Bai
A study recently published in Brain and Behavior has shown that certain magnetic resonance imaging (MRI) parameters correlated with a greater risk of recurrence and progression to multiple sclerosis (MS) within the first year following diagnosis of clinically isolated syndrome (CIS).
A study recently published in Brain and Behavior has shown that certain magnetic resonance imaging (MRI) parameters correlated with a greater risk of recurrence and progression to multiple sclerosis (MS) within the first year following diagnosis of clinically isolated syndrome (CIS).

CIS is a precursor to MS in many patients eventually diagnosed with the disease. However, the uncertainty of progression following the first episode of CIS, with some patients not progressing to MS until many years later, hinders decision making on the optimal time for treatment initiation in these patients. Being unable to differentiate between patients who are at higher risk of progression to MS within 1 year versus those at lower risk puts a greater strain on physicians, who have to decide whether patients require treatment shortly after their initial CIS episode.

Results from previous studies, which sought to identify key MRI and patient parameters that would predict long-term outcomes for patients after their first CIS attack, served as a baseline. However, these studies failed to analyze patient conversion to MS within the first year following CIS. The current research seeks to address this question and to help identify specific MRI parameters that correlate with progression within the first year of CIS.

Of the 46 patients who were analyzed for disease recurrence, 21 had no recurrence within the first year while 25 had another clinical episode. Lesion location, number of lesions, and lesion length were notably different between the 2 outcomes. For lesion location, the temporal lobe, occipital lobe, and the area perpendicular to the corpus callosum were significantly more involved among the 25 patients who progressed to MS. The number of lesions and lesion length were also both greater in patients who progressed compared to those who did not.

Upon further inspection of the results, researchers determined that patients with greater than 13 lesions, lesion length greater than 0.75 cm, and the presence of lesions perpendicular to the corpus callosum had a 19 times greater risk of developing a second episode.

Based on the observations following MRI imaging, several markers were identified that could predict a higher risk of recurrence within the first year. The number of lesions, lesion length, and presence of lesions perpendicular to the corpus callosum seen on the MRI scan may help physicians to recognize patients who may require earlier treatment with disease-modifying drugs.

While the low number of patients enrolled in this study warrants additional trials to validate these MRI parameters, these results established MRI as a highly valuable tool to determine the prognosis of MS throughout the duration of the disease. If MRI parameters are verified to be able to pinpoint certain high-risk patients of progressing to MS within the first year from the CIS event, it will greatly improve treatment decisions for physicians.

:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 

CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: 
                      
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Healthy Diet May Lower Risk of Developing MS, Study Finds


People who eat a healthy diet that includes foods such as vegetables, fish, eggs, poultry, and legumes may have a reduced risk of multiple sclerosis (MS), a study suggests.
Although diet may be a modifiable risk factor for MS, current evidence is mainly based on single foods and nutrients, with inconclusive results.
For example, one study found that eating fish once a week, or one to three times per month, along with taking daily fish oil supplements, may help lower the risk of developing MS. Another study showed that higher intake of antioxidant nutrients, such as vitamin C and E, does not reduce the risk of MS in women, as previously thought.
Instead, analyzing dietary patterns has advantages over the single food or single nutrient approach “by capturing information about a person’s total diet, including the interactions that may occur between food components,” the authors wrote.
Researchers at Curtin University in Australia investigated the associations between dietary patterns and the risk of a first diagnosis of central nervous system demyelination, a common precursor to MS.
“There are a number of known environmental risk factors for MS, including low vitamin D status and low sun exposure, smoking, and a history of glandular fever, and we were intrigued to see whether diet and food intake also played a significant role in this,” study lead author Lucinda Black, PhD, said in a press release.
The team collected data from the 2003-2006 Ausimmune study, a multicenter, case-control study conducted across Australia, and assessed if “a healthy diet or a western-style diet had an impact on the chances of having a demyelinating event, which involves damage to the myelin sheath that protects the nerves,” Black said.
A total of 698 participants (252 cases and 446 controls, matched in age, sex, and study region) who responded to a food frequency questionnaire concerning dietary patterns were included in the study.
Results were adjusted for body mass index, education, race, smoking habits, serum 25-hydroxyvitamin D concentrations, history of infectious mononucleosis, and dietary misreporting.
Two major dietary patterns were identified: healthy (high in poultry, fish, eggs, vegetables, and legumes) and Western (high in meat, full-fat dairy; low in wholegrains, nuts, fresh fruit, and low-fat dairy).
A healthy diet was associated with a 25% reduced risk of a first clinical diagnosis of  central nervous system demyelination. However, no statistically significant association between the Western dietary pattern and risk of a first clinical diagnosis of central nervous system demyelination was observed.
“Our results suggest that following a healthy diet characterised by poultry, fish, eggs, vegetables and legumes may lower the risk of [central nervous system demyelination],” the researchers wrote in the study.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 
                      
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Cognitive Impairment and Multiple Sclerosis

Cognitive Impairment and MS

Cognitive impairment is an area of MS that is often overlooked, as the common deficits caused by the condition concern motor skills and vision, despite cognitive impairment showing prevalence rates of 43% to 70% at earlier and later stages of the condition. Cognitive problems can appear independently of the physical problems caused by MS, which further complicates their identification.     (continue reading below video block)


Cognitive functions affected by MS include:
  • Long-term memory
  • Attention
  • Efficiently processing information
  • Executive functioning (ability to plan and anticipate outcomes in complex goal-orientated tasks)
  • Deficits in processing speed
Processing speed, visual learning, and memory are thought to be the most commonly affected areas in MS.

Long-Term Memory

Long-term memory is most commonly impaired cognitive function in MS with rates of 40% to 65%. Recent research has shown that the main cause for long-term memory impairment is less to do with difficulties in the retrieval of information, and more to do with the initial learning of the information. Patients with MS require information to be repeated more, but once the information has been learned, they can recall the information at the same levels as patients without MS. Other factors related to learning abilities affected by MS include slow processing speeds and difficulty to disregard irrelevant information or stimuli.

Attention

The processes identified under ‘attention’ are very varied, and as such concrete conclusions about the effect of MS on attention, processes have been difficult to make. Maintaining sustained attention is typically affected, as well as the ability to multitask.
Fatigue is also a factor that can affect attention processes, in particular, the ability to hold attention for long periods of time, but is often overlooked.

Information Processing

Problems with information processing have been seen across the disease course and are one of the most commonly seen cognitive symptom of MS. The ability to maintain information for a short period of time, also known as working memory, is negatively affected by MS. Impairment in information processing is usually seen concurrently with the other cognitive deficits in MS. Processing speed can be used to predict a patient’s long-term cognitive decline and also predict their performance in everyday tasks.

Executive Functioning

Defined as the cognitive abilities necessary for goal-directed tasks and complex decision making and adaptation to changes in the environment, executive functioning is one of the less frequent deficits seen in patients with MS.
Executive tasks include:
  • Abstract and conceptual thinking.
  • Planning and organization.
  • Fluency.
  • Anticipate outcomes.
Deficits in fluency see patients struggle with both phonemic (letter and word fluency) and semantic fluency (word category fluency). Depression affects the measurement of executive functioning and should be taken into account when examining and interpreting a patient’s performance in executive functioning.

Processing Speed

A reduction in processing speed is the most common cognitive area affected by MS, and deficits are seen concurrently with other areas of decline. The effect on a patient’s working memory is less than on their processing speed there is a positive correlation between increased demand on working memory and deficits in processing speed.
A sensitive test of cognitive dysfunction is a paced auditory serial addition test (PASAT), which tests working memory that puts a high demand on a patient’s processing speed.

Treatment of Cognitive Impairments in MS


..........................

Probiotics Increase Punch of Treatments That Decrease Inflammation in MS, Study Shows

Probiotics increased the punch of treatments that decrease the inflammation associated with multiple sclerosis, a study found.
Using the supplements to add helpful bacteria to the gut may be a way to improve patients’  outcomes, researchers added.
The team from Harvard University-affiliated Brigham and Women’s Hospital did not look at whether probiotics can improve MS itself, however — only at whether it can help reduce the inflammation linked to the disease. additional studies should explore this possibility, the researchers said.
Probiotics contain live bacteria that many scientists believe improve gut health. Recent research has shown that gut microbes can affect how the immune system works. Since MS is an autoimmune disease — or one in which the immune system attacks healthy organs and tissue — this suggests the microbes could improve MS.

Smoking Increases Relapse Rate in RRMS Patients on Tysabri, Study Suggests

 August 7, 2018
Smoking increases the relapse rate in patients with relapsing-remitting multiple sclerosis being treated with Tysabri , an observational study suggests.
Multiple sclerosis is a multifactorial disease associated with both genetic and environmental risk factors. Smoking, in particular, has been linked to numerous aspects of MS, including its development and progression.
(continue reading below photo)
Tysabri and smoking
In a previous study, the research team looked at how smoking influences the relapse rate in RRMS patients being treated with interferon beta. From more than 800 patients, they found that smoking one pack per day (about 20 cigarettes) essentially interfered with the positive effect of the IFN-beta treatment and increased the relapse rate by 27%.
The researchers then questioned whether the same was true for other treatments.
Tysabri, developed by Biogen, is a monoclonal antibody that targets the alpha-4 integrin protein. By interfering with this molecule, the therapy prevents white blood cells from moving into the central nervous system, suppressing the immune reaction that contributes to MS symptoms.
In the study, 355 Tysabri-treated RRMS patients from the Danish Multiple Sclerosis Centre were assessed. To gather information on smoking habits and body mass index, the patients filled out a 100-question survey. Data was collected between the start of the treatment and a two-year follow-up visit.
Results showed that smoking one pack of cigarettes per day increases the relapse rate by 38% in RRMS patients on Tysabri.
This increase in relapse rate takes into account both sex and age at the start of treatment, since age can affect the relapse rate. For example, an increase in age by one year raises the number of relapses by 2%.
The researchers also looked at the relationship between smoking and the presence of two immune-related alleles: HLA-DRB1*15:01 and HLA-A*02:01. Previous studies showed that HLADRB1*15:01 is associated with an increased risk of developing MS, while HLA-A*02:01 is linked to a decreased risk.
Although previous studies reported a link between smoking and these two alleles in MS patients, the current study did not find an association between smoking and carrying either of these alleles.
Based on the results, the researchers concluded that smoking significantly increases the relapse rate in RRMS patients receiving Tysabri.
According to the team, the results "add important information that hopefully will sharpen the focus on the overall harmful effects of smoking in MS patients."

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 


Quanterix’s Simoa Assay May Make Neurofilament Light Chain Useful Blood Biomarker of MS and Its Likely Progression

August 8, 2018

Quanterix’s ultra-sensitive Simoa assay has the potential to open new uses for the brain biomarker known as neurofilament light chain, including the possibility to detect early evidence of neurological diseases like multiple sclerosis (MS), Parkinson’s, and Alzheimer’s, and ably evaluate efforts to treat and prevent them, the company reports in a press release.
A hallmark of MS is the progressive degeneration of brain cells. As these cells are damaged, a protein called neurofilament light chain, or NfL, is released into cerebral spinal fluid and blood.
Studies have suggested that blood levels of NfL provide a reliable picture of MS activity, and could also be used to monitor disease progression, instead of magnetic resonance imaging scans of the brain. However, NfL’s use as a diagnostic marker for MS and other neurological disorders was limited due to lack of sensitive and reliable methods to assess it.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 

CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: 

                      
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Long-term DMT Use Seen to Lower Likelihood of RRMS Progressing to SPMS in Study



Long-term treatment with disease-modifying therapies (DMTs) appears to lessen the risk of disease worsening in relapsing-remitting multiple sclerosis (RRMS) patients, an 18-year follow-up study suggests.
But these therapies were not seen to benefit those who had progressed to secondary progressive multiple sclerosis (SPMS).
Disease-modifying therapies (DMTs) are treatments that aim to reduce MS progression from relapsing–remitting forms of the disease to SPMS.
Researchers conducted a retrospective analysis of 1,709 patients registered at the Group for Research and Treatment of Multiple Sclerosis (GITEM) Registry in Valencia, Spain.
Out of the initial 1,709 patients, 225 were clinically diagnosed with MS and 204 received treatment with first-line DMTs — interferon beta (Biogen‘s Avonex, among other brand names) or glatiramer acetate (sold as Teva‘s Copaxone).
Treatment with DMTs began when patients experienced at least one relapse in the previous year or two relapses within the previous three years. RRMS patients were followed for a median of 18.1 years.
Patients who failed to respond to treatment were given second-line therapies, namely the immune suppressants Novantrone (mitoxantrone), cyclophosphamide, or selective second-line DMTs, such as Tysabri (natalizumab) or Gilenya (fingolimod).
Study participants were evaluated regularly — every three to six months — for changes in their Expanded Disability Status Scale (EDSS) scores, relapse rates, and for side effects or decisions to stop treatment.
Progression to SPMS was confirmed “when patients with a previous EDSS score of 3.0 or greater experienced a six-month worsening to EDSS 4.0 or greater without evidence of relapse,” the researchers wrote.

:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 

CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: 

                      
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Thursday, August 16, 2018

Diets high in vegetables and fish may lower risk of multiple sclerosis

August 15, 2018, Curtin University
diet
Credit: CC0 Public Domain

People who consume a diet high in vegetables and fish may have a reduced risk of multiple sclerosis, new research led by Curtin University has found.

The research, published in the Multiple Sclerosis Journal, found an association between a higher intake of healthy foods, such as vegetables, , eggs, poultry and legumes, and a lower risk of  (MS).
Lead author Dr. Lucinda Black, from the School of Public Health at Curtin University, said the study investigated the links between dietary patterns and the risk of a first clinical diagnosis of central nervous system demyelination, a common precursor to MS.
"There are a number of known  for MS, including low vitamin D status and low sun exposure, smoking, and a history of glandular fever, and we were intrigued to see whether diet and  intake also played a significant role in this," Dr. Black said.
"We reviewed dietary intake data from the Ausimmune Study, a multicentre, case-control study conducted across Australia in Brisbane, Newcastle, Geelong, the western districts of Victoria, and Tasmania, and then assessed whether a healthy diet or a western-style diet had an impact on the chances of having a demyelinating event, which involves damage to the myelin sheath that protects the nerves.
"We found that a higher intake of healthy foods, such as  and fish, was associated with a lower risk of MS, with around a 50 per cent reduced risk in those who had the highest intake of healthy foods, compared to those with a much lower intake. This finding is especially relevant to those who currently consume low amounts of these foods."
Dr. Black explained that while there is no known cure for MS, the research could have potential implications for improving people's diets to help reduce the risk of MS in those who are at high risk.
"As MS is a condition that currently cannot be cured, it is important to provide accurate advice to people who are at a higher risk of getting the condition, as this could help to improve their lifestyle and diet," Dr. Black said.
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 

CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: 

                      
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Number, Location, Size of Lesions on MRI Can Predict Progression to MS, Study Shows

MS lesions














The number, location, and size of lesions can help predict the risk of progression from clinically isolated syndrome (CIS) to multiple sclerosis(MS) within one year, a new study shows.

Most patients diagnosed with MS initially present with CIS. In 50-70% of patients, magnetic resonance imaging (MRI) is taken at the time of CIS diagnosis, and it usually reveals multiple white matter brain lesions that suggest the presence of demyelination (or myelin loss, the process that underlies the pathology of MS).
::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

To receive MS news and information via e-mail, Please Click here 

CLICK BOX to SUBSCRIBE to our MS Learning Channel on YouTube: 

                     
:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::